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Abstract
A fibroblast-inhibiting agent, chloroquine, used in the treatment of animal tumors led to a
reasonably good result, and this approach was extended to the treatment of human cancers. Of
histologically proven 54 cases, the drug was effective in 38, ineffective in 15, and unknown in
one. It proved to be effective in all the patients who were treated for over 2 months with exception
of terminal patients. Of the various malignant tumors treated, excellent therapeutic effects were
obtained in patients with carcinoma of the lung and bladder. In the cases where the drug was
effective there were a decrease of the size of tumors, fall of serum lactic dehydrogenase, increase of
necrosis, inhibition of the stroma, as well as improvement of the symptoms and general condition.
As to the mechanisms of the drug action, it would be necessary to consider of its anti-inflammatory
and humoral effects upon the host in addition to its inhibitory action on the stromal connective
tissue of cancers. The present chloroquine treatment appears to have its indication in inoperable
cases, and pre- and post-operative cases, and for the prevention of reccurrence of tumors. Studies
are currently in progress in our laboratory to discover more potent fibroblastinhibiting agents and
on the combined chemotherapy of chloroquine and other anti-turnor agents. We are indebted to
the Department of Urology of our University for the generosity to allow us to use the clinical data
on patients with cancer of the urinary bladder.
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The present day measures against malignant tumors includes early detec-
tion, surgical removal, irradiation therapy, and administration of anti-tumor
agents, none of which, however, is far from being satisfactory. Of these,
search for so-called anti-tumor agents has long been made, and many chemical
agents and antibiotics have been tested for their possible carcinostatic activities.
Chemotherapy of malignant tumors thus far has been directed to the attack of
tumor cells themselves. Unfortunately, however, side effects of most of the
anti-tumor agents made it impossible to continue the drugs. The same can be
said of the irradiation therapy of cancer. With these approaches it would be a
very difficult task to eliminate malignant tumors without doing any harm to
normal tissues. It is conceivable that inhibition of the growth of the stromal con-
nective tissue of cancer, which is apparently of a vital importance to the support
of parenchymal cancer cells, will secondarily bring about deleterious effects on
the latter.
Already several years ago, we observed a dramatic effect of chloroquine
on Wakana-disease and bronchial asthma. Subsequently, it was shown that the
agent has a potent fibroblast-inhibiting action1•4, and clinically the drug proved
of a considerable value inhibiting the progression of fibrosis of the liver.
Accordingly, in view of the role of the stromal tissue of cancer, since 1960 we
have come to use chloroquine in an attempt to suppress the growth of the young
fibroblastic stroma intrinsic to malignant tumors1•2• S•4,5. As reported previously,
the effects of the drug upon transplantable animal tumors were satisfactory,
and the present paper deals with its clinical application.
MATERIALS AND METHODS
One hundred and three patients with various 'malignant turnors, the ma-
jority of which were inoperable, were treated with chloroquine. The treatment
effects were evaluated on 54 of them, who were histologically proven to have
carcinomas either by biopsy, operation, or autopsy. Of these 54 patients, 46
were admitted to our Department of Internal Medicine, and the remaining 8
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were treated at the Department of Urology for carcinoma of the bladder.
All these patients received either 250 mg of chloroquine diphosphate or
200 mg of chloroquine diorotate usually once or twice daily by slow intravenous
injection. The drug was injected slowly over five minutes. We made it a rule
to give the drug as long as possible, and the longest duration of therapy ever
attained was approximately one and a half years. Since the cancer is an irrever-
sible disease, the criteria for the evaluation of treatment were as follows. Those
obtaining subjective or objective improvement were classified as effective, those
showing arrest of aggravation of symptoms and some relief of symptoms as
slightly effective, and those running a downhill course as ineffective.
In the course of treatment, X-ray examination, gastrocamera, peritoneo-
scopy, and cystoscopy were performed as indicated. Histological studies, deter-
mination of serum lactic dehydrogenase, alkaline phosphatase, transaminase,
cholinesterase, serum iron and copper were also done. Furthermore, organ
concentrations of chloroquine on autopsied cases were measured by the method
of BRODI~.
RESULTS
Of the 54 patients, 38 obtained drug effects interpreted as effective. These
38 patients comprised 11 cases of lung carcinoma, 11 cases of gastric carcinoma,
6 cases of bladder cancer, 4 cases of peritonitis carcinomatosa, two cases of recur-
rent colon carcinoma, and one case of advanced carcinoma of the liver, pancreas,
breast, and uterus, respectively. On the other hand, the drug was ineffective
in 15, and unknown in one. The patients we treated varied in the state of prog-
ression of the disease, and they were divided in two groups, to separate terminal
cases, depending upon the duration of treatment. It was found that those 15
patients, in whom the drug was ineffective, received chloroquine for less than
two months, while those placed on the drug for over 2 months obtained some
sort of beneficial effect for a certain period of time except the one unknown case
(Tables 1, 2).
In carcinoma of the lung, the therapeutic effects of the drug were more
pronounced, providing improvement in 11 of 12 patients treated. Subjective
complaints such as dyspnea, cough, chest pain and sense of pressure tended
to improve within a day at the earliest and usually within a week after the
start of treatment. This initial response was followed either by an asymptomatic
phase of 10 months or in some patients by aggravation accompanied by the
presence of pleural effusion. In those with mediastinal involvement, mitigation
not only of dyspnea but of facial edema and venous dilatation was noted. An
increase of the dosage of chloroquine induced gross hemoptysis in two patients
with lung cancer. Improvement in the chest X-ray films was demonstrable in
2
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Treatment of Malignant Tumors with Chloroquine
Table 1 Therapeutic effect of chloroquine on patients with various kinds of cancers
73
I Number Therapeutic effectI
Cases
I of
I
moderately I
II
cases effective
effective failure obscure
Lung cancer 12 11
I
1
* Gastric cancer 19 7 4 7 1
Bladder cancer 8 6
I
2
Peritonitis carcinomatosa 5 3 I 1 1
I
** Intestinal cancer 2 1
I
1
Liver cancer 5 1 !
I
4
I
Pancreatic cancer 1 1 I
I*** Uterine cancer 1 1
i I
I
**** Breast cancer 1 1
I
Total 54 32 6 15 1
* Include 1 case with postoperative liver metastasis
** Postoperative relapse
*** Intestinal invasion
**** Postoperative lung metastasis
Table 2 Period and effect of therapy with chloroquine in patients with
various kinds of cancers
Number Therapeutic effect
Period of therapy of
moderately
cases effective
effective failure
_more than 2 months I 22 19 2 0
less than 2 months I 32 13 4 15
obscure
o
many cases in about a week after the start of therapy and became apparent in
3-4 weeks. There were a decrease of the size of tumors and tumor opacities,
delineation of the tumor margin due to a decrease of the surrounding infiltrations,
and a decrease of atelectatic changes. There were cases, however, in which no
improvement was seen in the X-ray films (Table 3, Figs. 1, 2, 3, Photos. 1, 2).
In carcinoma of the stomach, about half of the patients were in the advanced
stage of the disease, and in 11 of 19 cases the drug was effective. Improvement
of the symptoms of abdominal distention, epigastric pain and vomiting followed
as early as a week and at the latest a month after the initiation of therapy.
Symptoms arising from stenosis of the cardia or pylorus often tended to be
alleviated by the administration of the drug. In one patient an abscess formation
in the abdominal wall ensued. Palpation of the abdomen, in some patients,
revealed a slight decrease of the size of the tumor or sharpened edge of the tumor
3
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s. O. Dyspnea
K. D. Cough
F. M. Mediastinal
syndrome
K. M. Cough
H. A. ~rr-{DJE Chest pain
S. 1. Dyspnea
K. S. Chest pain
K· O. Cough
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Table 3 Therapeutic effect of chloroquine on lung cancer
Case Name Age Chief Histology Period of Improvement Improvementnumber Sex complaint treatment of subj. symp. of obj. symp.
1 5.0. 56 Dyspnea Undifferen- 11 months + +Jf tiated carc.
2 K.D. 58 Cough Squamous 8 11 + ±
'0 cell care.
3 K.M. 47 11 11 5/3 11 + +
'0
4 F.M. 46 Dyspnea 11 5
" + +'0
5 5.1. 49 11 11 3/2 11Jf T
6 M.Y. 73 Chest pain 11 1/2 11
'0
7 H.A. 62 11 11 3 11 + ±Jf
8 5.5. 67 11 Undifferen- 18 11 +Jf tiated care.
9 K.O. 70 Cough 11 8 11 + +
'0
10 S.H. 57 Emaciation 11 8 11 / +0
11 F.N. 35 Cough Adenocarc. 1 11 +Jf
12 S.W. 54 Facial Undifferen- 2 11 + +
'0 edema tiatedcarc.
13 S.Y. 65 Dyspnea Adenocarc. 4 11 + +Jf
The period
Case Name ( Number of days)
number of Chief
_________________ J~~~_~~~_t~ J ? ~ 1: ~ __ .~. ? ~ __ . ~~~.~.~~~_~~._
1
2
3
4
5
6
7
8
Fig. 1 Period required by chloroquine to exert its therapeutic effect on patients with
lung cancer
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Chloroquine diphosphate
(Intravenous injection)
Number of months
500
250
..q
1 2 :3 4 5 6 ? 8 9 10 11 12
170310
...+-""'-----------------------------1
~ -~
380S.L,D.H.
Hemoptysis
Pleural effusion
'"Cough ::: ,.... --... ..IL __
'"Dyspnea ~~ _
-If!-
Pressure sensation ~ ~ '-a...j
-If!-
Chest pain :::,-.. _
'"+t
Fig. 2 Lung cancer (Undifferentiated carcinoma), S. O. 61y. Sf
Chloroquine diphosphate ~gg:::+::-':':':-.,.,--_-:":"----~:_C:'":_7--~,.",.,.,~=cc-.-:"':'_,_=:_:.'T;':",'"C'7-::_:-:'"--,-:7T:--;:.,.,,;~_::'7.:':'C.-:-","~C"',"7---:-.".,-::"""::rl---,( Intravenous injection) --j.:.L-OO=-,,'.:..o..;..;.;.;.;..c:.:=""'~""'-'-'-"---'-""~1~~~=-:"~~~~2=-i
Number of months
Cough
Sputum
Metastasis Regression in size
(subclavicular)
Fig. 3 Lung cancer (Undifferentiated carcinox.na), K. O. 70 y. 0
following the treatment. On X-ray examination, a few patients with stenosis
showed a marked improvement, but in general changes were not so impressive
as in lung cancer. Gastrocamera examination disclosed clearing of the mucous
membrane and a slight decrease of the size of the tumors in some cases. Two
patients who obtained a marked relief of stenotic symptoms had scirrhous carc-
inoma (Figs. 4,5,6, Photo 3).
Abdominal pain
pain
pain
Vomi ting
Vomiting
Filling
sensation
Epigastric
Abdominal?
The period
Case Name (Number of days) Chief
number of complaint
patients 10 20 30
-------- --- -- -- --------------------- ---.--- *- ------ -- --if\-- ---.- -- .•.*.---- --- -----... _.
1 y. K.
2 S. Y.
:3 H. T.
4 S. S.
5 M. K.
6 M. Y.
Fig. 4 Period required by chloroquine to exert its therapeutic effect on patients with
gastric cancer
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?4 52 3
:!:..JIII-...IIL------- ---------1:!:.JI------- ------....-------1
Chloroquine diphosphate 500
(Intravenous injection) 2~~.~:.~,.:~~:~,.~>:~~:~:,~.;~~.,~.~.,~. ~ ~~,:-~:.:!~.~'=:'=~~~/:=j,~:~=~:~,~·.~!:~::~~:r~:'~'!·~~~~~j~::.:~)~:~;;
Number of months
Epigastric distress
Nausea
Vomiting
Filling sensation
Generalized fatigue
Body weight unchanged or increaSe! decrease
Blood picture improved
Fig. 5 Gastric cancer (Carcinoma simplex), Y. K. 61 y. .!f
1
Chloroquine diorotate 400
(I ntravenous injection) 2~t:=L_':X.C';~·
Number of months 5
Nausea
Vomi ting
Filling sensation
Anorexia
-11+
++
+
------------------1
Body weight increase
Stomach X-ray Disappearance of gastric dilatation
Fig. 6 Gastric cancer (Adenocarcinoma), M. Y. 48y. 0
In four of the five patients with peritonitis carcinomatosa, the drug was
effective, and there was a decrease or disappearance of the sense of abdominal
distention and ascites (Figs. 7, 8).
500"'9~, 125""/250"~
.,
.·0
s 1 2 3 4 5 6 7
#+
ss ++1...
+
1#It I..
-
ue H
+H
+1-.
:1..-
-
Chloroquine diphosphate
(Intravenous injection)
Number of month
Epigastric distre
Filling sensation
Generalized fatig
Anorexia
Asci tes
Serum iron normalized
Blood pictures improved
Body weight improved
Fig. 7 Peritonitis carcinomatosa (Adenocarcinoma) M. K. 48y. .!f
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500'"1' .-.---------.-- .- ----...- ..- ..----------.. 1
250m~1 "~_;;-'; ,:;',,',':,:,i::::;: .. ':;:-;:-~::"':,S,L·:,:·,rI:;:·;'7Z.:1._._'
_ .. ..... J L .__. . S
Chloroquine diphosphate
(Intravenous injection)
Number of months
Filling sensation
Epigastric distress
Nausea
Generalized fatigue
Edema
Ascites
Abdominal circumference decreased
Fig. 8 Peritonitis carcinomatosa (Adenocarcinoma), Y. N. 67y. 0
One patient with hepatoma showed a decrease of the tumor size and im-
provement of the genereal condition, but four other hepatoma cases barely
responded to the therapy because of the rapidly progressing late stage of the
disease. Chloroquine was fairly effective in advanced cases of carcinoma of the
pancreas, intestine, breast, and uterus.
It is of note that alleviation of pain was observed in all the cases treated.
Metastatic nodules also became smaller in a few instances. In a large number of
cases, there was improvement of anemia, erythrocyte sedimentation rate, serum
protein and body weight. The serum lactic dehydrogenase was decreased in all
the drug-responsive cases in which it was determined. The serum iron occa-
---Cases with therapeutic success
...... Cases with therapeutic failure
L.D.H.
(Unit)
300
200
Before
treatment
After
treatment
Fig. 9 Changes of S. L. D. H. with chloroquine treatment of cancer
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50 100 150
Y/ gram
+
+
Lung
Lung near tumor
Turnor i tse1f
Adrenal glands
Bone marrow
Heart
Spleen
Liver
Liver metastasis
Kidney
PUlm. lymphnodes
Muscle
(pectoralis
major)
Fig.}{) Organ distribution of chloroquine in autopsied cases of lung cancer
sionally showed a slight elevation. There was no significant alteration in the
values of alkaline phosphatase, transaminase, cholinesterase and serum copper.
At autopsy softening and an increase of necrosis of the tumors were observed
macroscopically or microscopically, although these changes were not solely
attributable to the action of the drug. The concentration of chloroquine in the
tumor tissue was found to be relatively small (Figs. 9, 10).
Chloroquine was effective in 6 of 8 patients with carcinoma of the bladder
treated at the Department of Urology, and in two of the six there was a marked
improvement. Improvement or disappearance of the subjective complaints such
as hematuria, pollakisuria and dysuria was frequently followed by the cystoscopic
findings of a decrease of the tumor size, flattening of the tumor, disappearance
of the daughter tumors or clearing of the mucous membrane. Histological changes
due to chloroquine were inhibition of the growth of the stromal connective tissue,
reduction of inflammatory cell infiltration and replacement of polymorphonuclear
cells with round inflammatory cells, while parenchymal tumor cells showed little
morphological changes (Table 4, Figs. 11, 12).
Chloroquine diorotate Before After 200111:/' 20 i!!jections(Intravenous injection), r- ~
Hematuria
Urinary
frequency
Cystoscopic
findings (.# -- )~-fJ/
Fig. 11 Urinary bladder cancer (Transitional cell carcinoma) M. S. 62y. ~
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Chloroquine diorotate
(Intravenous injection)
Urinary distress
Hematuria
Urinary frequency
Cystoscopic findings
Before After 200"',/'-, 14 injections
Fig. 12 Urinary bladder cancer (Transitional cell carcinoma) E. O. 67 y. ~
Table 4 Therapeutic effect of chloroquine diorotate on urinary bladder cancer
Case N Age Chief
number ame Sex complaints Histology
Period of Improvement
treatment of subj. symp.
Change observed
with cystoscope
1 K.S. 66 Hematuria~
Transitional
cell carcinoma 26 days improved
Tumor-.nochange
Mucosa--c!ear
2 M.S.
62 Hematuria
Urinary
(; frequency
11 20 11 disappeared
Tumor-·regression
in size
Daughter tumor--
disappeared
Hyperemia-.
disappeared
Tumor.-prominent
regression
in size
Hyperemia--
disappeared
Tumor·-flattening
volcano type
11
improved
14 1111
Urinary
distress
67 Hematuria~ Urinary
frequency
43 Urinary
distress Undifferentiated 26 //~ Hematuria carcinoma
£.0.
S.l.4
3
5 E.F. ~ Hematuria Transitionalcell carcinoma 13 11 no evidentchange
Tumor··some reg-
ression in size
Surrounding inva-
sion--disappeared
Border of neck--
clear
6
7
C.T.
Y.M.
~ Hematuria
64 Hematuria
Urinary
(; frequency
Adenocarcinoma
Transitional
cell carcinoma
8 11
15 11
1/
disappeared
no evident change
//
8 S.T.
Hematuria
Urinary
62 frequency~ Urinary
distress
1/
20 1/ no evident
change
Side effects of the drug were slight, and 8 of the 54 patients had nausea,
anorexia, dizziness or blurred vision but no leukopenia. Gastrointestinal com-
plaints were most frequently observed but even in these cases prolonged admi-
nistration of the drug could be maintained by decreasing the drug dosage or
9
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by combining ATP preparation. Transient vertigo or diplopia that was occasio-
nally seen immediately after injection of the drug could be minimized by giving
the drug very slowly with patients in the recumbent position (Table 5).
Table 5 Side effect of chloroquine (in 54 carcinoma cases)
Side effect No. cases
Gastrointestinal
symptoms
Neurological
symptoms
Ophthalmic
symptom
Nausea
Anorexia
Sense of fullness
Dizziness
Drowsiness
Blurred vision
DISCUSSION
2
2
2
1
1
Chloroquine was effective in patients with various cancers except far ad-
vanced cases, and the drug was of particular benefit in carcinoma of the lung
and bladder. Improvement of the subjective complaints occurred early and could
be dramatic. It is to be noted that even the intractable pain commonly seen in
almost all the cancer patients could be alleviated. The fact that some of the
human tumors became smaller after treatment while the drug merely inhibited
the growth of animal tumors is suggestive of its superior drug effects in human
cancers.
The periods from the start of treatment to the time when patients obtained
beneficial effects differed among various tumors. That patients with lung cancer
were usually benefited shortly after the initiation of therapy could be explained
by the probable higher concentration of the intravenously injected drug in th~
lesser circulation. In gastric cancer many patients are asymptomatic and it is
difficult to accurately pursue the effects of the drug, but those with stenotic
symptoms, particularly two patients with scirrhus, were greatly relieved. A
necrosis-inducing action of chloroquine as stated earlier, might have been respon-
sible for gross hemorrhage in two cases of pulmonary cancer following an in-
crease of the drug dosage and formation of an abdominal abscess in one case of
gastric cancer. The cancer patients treated with the drug did not complain much
of the intractable pain which we commonly encounter in cancer clinic. The
excellent effects of the drug in peritonitis carcinomatosa reconcile with some of
the in vivo experiments1,2,;:,6. The in vitro experiments1. 2.3.6 have excluded a
possibility of the direct drug action on cancer cells in the peritoneal cavity, and
its effects upon the host should be considered important. This humoral effects
10
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as well as its anti-inflammatory action3.4.7 should be taken into acc ount to explain
the early relief of symptoms in scme of the cancer patiEnts. ThEse and other
multiple drug actions of chloroquine are now under investigation.
Our previous experiences with chloroquine in the treatment of several
hundred cases of bronchial asthma have indicated that the drug has no serious
side effects incapacitating its prolonged administrations. The drug, under the
dosage employed, could be used without any harm such as leukopenia as is often
seen with other anti-tumor agents.
The majority of the cases of carcinoma of the lung, bladder and stomach
responding to the present therapy were those in the non-terminal stage of the
diseases of the slowly progressing type. This indicates that the drug, when used
in the early stage, may considerably prolong the life-span of cancer patients.
We believe from the present studies that chloroquine is indicated as a drug of
choice for those who are not yet cachectic but enough advanced to be inoperable,
and for postoperative cases to prevent the reccurrence of tumors. Search is being
made for a more potent fibroblast-inhibiting agent, and clinical and basic studies
are in progress on the use of chloroquine in conjunctin with other so-called anti-
tumor agents and for prophylaxis of the development of tumors.
SUMMARY
A fibroblast-inhibiting agent, chloroquine, used in the treatment of animal
tumors led to a reasonably good result, and this approach was extended to the
treatment of human cancers.
Of histologically proven 54 cases, the drug was effective in 38, ineffective in
15, and unknown in one. It proved to be effective in all the patients who were
treated for over 2 months with exception of terminal patients. Of the various
malignant tumors treated, excellent therapeutic effects were obtained in patients
with carcinoma of the lung and bladder. In the cases where the drug was effec-
tive there were a decrease of the size of tumors, fall of serum lactic dehydro-
genase, increase of necrosis, inhibition of the stroma, as well as improvement of
the symptoms and general condition.
As to the mechanisms of the drug action, it would be necessary to consider
of its anti-inflammatory and humoral effects upon the host in addition to its
inhibitory action on the stromal connective tissue of cancers. The present chloro-
quine treatment appears to have its indication in inoperable cases, and pre- and
post-operative cases, and for the prevention of reccurrence of tumors. Studies
are currently in progress in our laboratory to discover more potent fibroblast-
inhibiting agents and on the combined chemotherapy of chloroquine and other
anti-turnor agents.
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We are indebted to the Department of Urology of our University for the generosity to allow
us to use the clinical data on patients with cancer of the urinary bladder.
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